| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 16 | 0 | 0 | 16 |
| GLS protein | 9 | 0 | 0 | 9 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 5 | 0 | 0 | 5 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 8 | 1 | 1 | 10 |
| ATP-dependent phosphofructokinase | 11 | 0 | 0 | 11 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 5 | 1 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 9 | 3 | 12 |
| 5-hydroxytryptamine receptor 1B | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 7 | 1 | 8 |
| Sodium-dependent serotonin transporter | 0 | 8 | 0 | 9 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| GALC protein | 3 | 0 | 0 | 3 |
| GLI family zinc finger 3 | 19 | 0 | 0 | 19 |
| nuclear receptor subfamily 1, group I, member 3 | 14 | 0 | 0 | 14 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
| glucocorticoid receptor [Homo sapiens] | 15 | 0 | 0 | 15 |
| retinoic acid nuclear receptor alpha variant 1 | 14 | 0 | 0 | 14 |
| retinoid X nuclear receptor alpha | 11 | 0 | 0 | 11 |
| estrogen-related nuclear receptor alpha | 17 | 0 | 0 | 17 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| arylsulfatase A | 8 | 0 | 0 | 8 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 15 | 0 | 0 | 15 |
| Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 16 | 0 | 0 | 16 |
| geminin | 13 | 0 | 0 | 13 |
| peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 7 | 3 | 2 | 12 |
| ATP-binding cassette sub-family C member 3 | 0 | 19 | 0 | 19 |
| Multidrug resistance-associated protein 4 | 0 | 19 | 0 | 19 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 2 | 1 | 6 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 24 | 0 | 24 |
| Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
| Renin | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 1 | 0 | 6 | 1 | 12 |
| Carbonic anhydrase 2 | 0 | 6 | 1 | 11 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 4 | 1 | 5 |
| Carbonic anhydrase 3 | 0 | 2 | 1 | 6 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 2 | 1 | 3 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 6 | 1 | 7 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 3 | 1 | 4 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 3 | 2 | 12 |
| Translocator protein | 0 | 2 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 3 | 2 | 12 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 5 | 1 | 8 |
| Carbonic anhydrase 6 | 0 | 3 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 3 | 2 | 12 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 6 | 1 | 10 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 3 | 2 | 12 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 3 | 2 | 12 |
| Adenosine receptor A2a | 0 | 5 | 1 | 11 |
| Delta-type opioid receptor | 0 | 7 | 1 | 9 |
| Cytochrome P450 2C19 | 0 | 5 | 1 | 6 |
| Delta-type opioid receptor | 0 | 5 | 2 | 7 |
| Mu-type opioid receptor | 0 | 6 | 3 | 9 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 1 | 7 |
| Carbonic anhydrase | 0 | 4 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 5 | 1 | 8 |
| Carbonic anhydrase 7 | 0 | 3 | 1 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 3 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 3 | 2 | 12 |
| Cholinesterase | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 6 | 1 | 7 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 1 | 6 |
| Squalene synthase | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 3 | 1 | 7 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
| GABA theta subunit | 7 | 3 | 2 | 12 |
| Canalicular multispecific organic anion transporter 1 | 0 | 18 | 0 | 18 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 5 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 3 | 0 | 5 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 7 | 3 | 2 | 12 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 1 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 1 | 7 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| AR protein | 25 | 0 | 0 | 25 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 8 | 0 | 0 | 8 |
| estrogen nuclear receptor alpha | 24 | 0 | 0 | 24 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| IDH1 | 5 | 0 | 0 | 5 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 6 | 2 | 9 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Glutamate receptor 2 | 8 | 0 | 0 | 8 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 3 | 0 | 3 |
| Adenosine receptor A2a | 0 | 5 | 5 | 13 |
| Adenosine receptor A2b | 0 | 2 | 1 | 6 |
| Adenosine receptor A2b | 0 | 4 | 1 | 7 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 6 | 4 | 15 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 2 | 1 | 3 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| USP1 protein, partial | 3 | 0 | 0 | 3 |
| Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
| lamin isoform A-delta10 | 15 | 0 | 0 | 15 |
| Chain A, 2-oxoglutarate Oxygenase | 10 | 0 | 0 | 10 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 5 | 0 | 0 | 5 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| TDP1 protein | 14 | 0 | 0 | 14 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| pregnane X nuclear receptor | 17 | 0 | 0 | 17 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 5 | 1 | 9 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 8 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 9 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
| Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 3 | 0 | 0 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 3 |
| Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 3 | 4 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 11 | 4 | 16 |
| Delta-type opioid receptor | 0 | 9 | 1 | 11 |
| Kappa-type opioid receptor | 0 | 9 | 3 | 13 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
| farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
| thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
| muscarinic acetylcholine receptor M1 | 8 | 0 | 0 | 8 |
| Cholinesterase | 0 | 4 | 0 | 4 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
| Replicase polyprotein 1ab | 0 | 4 | 1 | 5 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 4 | 0 | 4 |
| Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 5 | 0 | 5 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 2 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 2 | 0 | 2 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 2 |
| Chitotriosidase-1 | 0 | 2 | 0 | 2 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 2 | 3 | 5 |
| Endochitinase B1 | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| Liver carboxylesterase 1 | 0 | 2 | 0 | 5 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 3 | 0 | 3 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 4 | 0 | 4 |
| Amyloid-beta precursor protein | 0 | 4 | 0 | 4 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 5 | 2 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 2 | 6 |
| D | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 9 | 1 | 10 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 5 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 2 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 5 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 10 | 0 | 10 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 5 |
| Sigma non-opioid intracellular receptor 1 | 0 | 7 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 4 | 0 | 4 |
| Leukotriene B4 receptor 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 4 | 0 | 4 |
| Transporter | 0 | 5 | 0 | 5 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 4 |
| Mu-type opioid receptor | 0 | 4 | 0 | 5 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| progesterone receptor | 8 | 0 | 0 | 8 |
| G | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 9 | 0 | 0 | 9 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 4 | 0 | 4 |
| Interferon beta | 6 | 0 | 0 | 6 |
| HLA class I histocompatibility antigen, B alpha chain | 5 | 0 | 0 | 5 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 2 |
| Albumin | 0 | 0 | 1 | 1 |
| Cellular tumor antigen p53 | 10 | 0 | 0 | 10 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 2 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 2 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 5 | 0 | 0 | 5 |
| ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
| Ataxin-2 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 5 | 0 | 0 | 5 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| SMAD family member 2 | 4 | 0 | 0 | 4 |
| SMAD family member 3 | 4 | 0 | 0 | 4 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 5 | 0 | 0 | 5 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 2 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | 0 | 1 | 0 | 1 |
| Protein farnesyltransferase subunit beta | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Luciferase | 6 | 0 | 0 | 6 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| D(2) dopamine receptor | 0 | 5 | 0 | 5 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 2 | 4 |
| Histamine H1 receptor | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 5 | 0 | 5 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 0 | 1 | 1 |
| Prostacyclin receptor | 0 | 2 | 1 | 3 |
| Prostacyclin receptor | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Prostaglandin D2 receptor | 0 | 0 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| Gap junction alpha-1 protein | 0 | 1 | 0 | 1 |
| Gap junction beta-2 protein | 0 | 1 | 0 | 1 |
| Acyl-protein thioesterase 1 | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear receptor ROR-gamma | 2 | 1 | 1 | 4 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 3 | 0 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| Phosphodiesterase | 0 | 3 | 0 | 3 |
| Vpr | 2 | 0 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Dual specificity protein kinase TTK | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 3 | 0 | 3 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 3 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 3 | 0 | 3 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Aurora kinase B | 0 | 1 | 0 | 1 |
| Inner centromere protein | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase 1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 2 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| Snq2p | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 1 | 1 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Procathepsin L | 0 | 1 | 1 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Trypanothione reductase | 0 | 3 | 0 | 3 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 3 | 0 | 3 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| chaperonin GroEL | 1 | 0 | 0 | 1 |
| Sulfotransferase 1A1 | 0 | 1 | 0 | 1 |
| Sulfotransferase 2A1 | 0 | 1 | 0 | 1 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Chain A, ACETYLCHOLINESTERASE | 0 | 1 | 0 | 1 |
| Chain A, liver Carboxylesterase I | 0 | 1 | 0 | 1 |
| Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| [Tau protein] kinase | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-4 | 0 | 1 | 0 | 1 |
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 1 | 3 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-3 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
| Coagulation factor XII | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2E1 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 0 | 1 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 1 | 3 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
| Gastrotropin | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-7 subunit | 0 | 1 | 0 | 1 |
| Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit epsilon | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-1 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent R-type calcium channel subunit alpha-1E | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-4 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-8 subunit | 0 | 1 | 0 | 1 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-6 subunit | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-4 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-5 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 13 | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
| Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 0 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 1 | 1 | 2 |
| Type-1B angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 2 | 1 | 4 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |